Cervical cancer remains a global public health problem with the annual number of new cases projected to increase from 570 000 to 700000 and deaths from 311,000 to 400,000 between 2018 and 2030.1 Unfortunately, about 85% of woman affected by cervical cancer are young, undereducated and live in the world’s poorest regions like sub-Saharan Africa including Nigeria.2 Although high income countries (HIC) have reduced morbidity and mortality from cervical cancer by about 80% using cytology (pap smears) for population-based screening cervices in the past 60 years, many low-middleincome-countries (LMIC) in sub-Saharan Africa have not been able to replicate it due to limited resources and challenges with the personnel, laboratory and logistics requirements, competing health needs and the appropriate political commitment.
Copyright © 2021 - All Rights Reserved - jmbr_new.org
Designed by University of Benin Web Unit